These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis. Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295 [TBL] [Abstract][Full Text] [Related]
10. Thyroid Ultrasonography in Differentiation between Graves' Disease and Hashimoto's Thyroiditis. Pishdad P; Pishdad GR; Tavanaa S; Pishdad R; Jalli R J Biomed Phys Eng; 2017 Mar; 7(1):21-26. PubMed ID: 28451576 [TBL] [Abstract][Full Text] [Related]
11. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158 [TBL] [Abstract][Full Text] [Related]
12. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)]. Ikekubo K Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Pani MA; Regulla K; Segni M; Krause M; Hofmann S; Hufner M; Herwig J; Pasquino AM; Usadel KH; Badenhoop K Eur J Endocrinol; 2002 Jun; 146(6):777-81. PubMed ID: 12039697 [TBL] [Abstract][Full Text] [Related]
14. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease. Tötterman TH; Andersson LC; Häyry P Clin Endocrinol (Oxf); 1979 Jul; 11(1):59-68. PubMed ID: 391444 [TBL] [Abstract][Full Text] [Related]
15. Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis. Gakiopoulou H; Litsiou E; Valaris K; Balafoutas D; Patsouris E; Tseleni-Balafouta S Endocr J; 2010; 57(8):693-9. PubMed ID: 20616436 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180 [TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of Graves' disease. Volpé R Endocr Pract; 1995; 1(2):103-15. PubMed ID: 15251604 [TBL] [Abstract][Full Text] [Related]
18. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460 [TBL] [Abstract][Full Text] [Related]
19. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464 [TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Ralli M; Angeletti D; Fiore M; D'Aguanno V; Lambiase A; Artico M; de Vincentiis M; Greco A Autoimmun Rev; 2020 Oct; 19(10):102649. PubMed ID: 32805423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]